Data show COVID-19 vaccine from Johnson & Johnson spurs immune response
January 14, 2021 at 09:14 AM EST
A one-shot COVID-19 vaccine developed by Johnson & Johnson is safe and generates an immune response to block the novel coronavirus that causes the disease, according to results of an early-stage clinical trial.
